amiodarone has been researched along with itraconazole in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (40.00) | 29.6817 |
| 2010's | 10 (50.00) | 24.3611 |
| 2020's | 2 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Dalvie, D; Loi, CM; Smith, DA | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Avdeef, A; Ruell, JA; Tsinman, O | 1 |
| Concepción, JL; Lanza, G; Márquez, E; Paniz-Mondolfi, AE; Pérez-Alvarez, AM | 1 |
| Gaud, N; Holenarsipur, VK; Kole, P; Kumar, A; Mandlekar, S; Matta, M; Sridhar, S | 1 |
| Anversa, L; Batista, LR; Cuba, MB; Dias da Silva, VJ; Martins, TY; Nogueira Nascentes, GA; Ramirez, LE; Richini Pereira, VB; Ruiz, LDS; Salles Tiburcio, MG | 1 |
| Benaím, G; Estep, JS; Luis Concepción, J; Madigan, R; Majoy, S; Márquez, ME; Mogollón-Mendoza, AC; Paniz-Mondolfi, AE; Pérez Alvarez, A; Ritter, K; Rodriguez-Morales, AJ; Silva, SC; Zao, CL | 1 |
| Berger, R; Chien, LC; Cooke, A; Madigan, R; Tomanek, L; Yang, YC; Zao, CL | 1 |
| Boutet, BG; Hamer, SA; Malcolm, EL; Saunders, AB; Vitt, JP | 1 |
| Duan, Z; Li, M; Liu, Y; Tong, J; Zeng, R; Zheng, N | 1 |
1 review(s) available for amiodarone and itraconazole
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
19 other study(ies) available for amiodarone and itraconazole
| Article | Year |
|---|---|
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Which metabolites circulate?
Topics: Humans; Metabolic Clearance Rate; Pharmaceutical Preparations | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Acid-base cosolvent method for determining aqueous permeability of amiodarone, itraconazole, tamoxifen, terfenadine and other very insoluble molecules.
Topics: Acids; Amiodarone; Hydrogen-Ion Concentration; Itraconazole; Permeability; Solubility; Solvents; Tamoxifen; Terfenadine; Water | 2004 |
Amiodarone and itraconazole: a rational therapeutic approach for the treatment of chronic Chagas' disease.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Chagas Disease; Chronic Disease; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Humans; Itraconazole; Male; Middle Aged; Trypanocidal Agents; Trypanosoma cruzi | 2009 |
Single jugular vein cannulated rats may not be suitable for intravenous pharmacokinetic screening of high logP compounds.
Topics: Administration, Intravenous; Administration, Oral; Amiodarone; Animals; Biological Availability; Blood Specimen Collection; Catheterization; Itraconazole; Jugular Veins; Male; Rats; Rats, Sprague-Dawley | 2017 |
Amiodarone and itraconazole improve the activity of pentavalent antimonial in the treatment of experimental cutaneous leishmaniasis.
Topics: Amiodarone; Animals; Cricetinae; Disease Models, Animal; Drug Therapy, Combination; Hindlimb; Histocytochemistry; Itraconazole; Leishmania; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Polymerase Chain Reaction; Skin; Treatment Outcome | 2017 |
Investigation of a combination of amiodarone and itraconazole for treatment of American trypanosomiasis (Chagas disease) in dogs.
Topics: Amiodarone; Animals; Chagas Disease; Dog Diseases; Dogs; Itraconazole; Louisiana; Texas; Trypanosoma cruzi | 2019 |
PCR monitoring of parasitemia during drug treatment for canine Chagas disease.
Topics: Amiodarone; Animals; Chagas Disease; DNA, Kinetoplast; DNA, Protozoan; DNA, Satellite; Dog Diseases; Dogs; Itraconazole; Parasitemia; Real-Time Polymerase Chain Reaction; Sensitivity and Specificity; Texas; Trypanocidal Agents; Trypanosoma cruzi | 2019 |
Antiparasitic treatment with itraconazole and amiodarone in 2 dogs with severe, symptomatic Chagas cardiomyopathy.
Topics: Amiodarone; Animals; Anti-Infective Agents; Antiparasitic Agents; Arrhythmias, Cardiac; Chagas Cardiomyopathy; Dog Diseases; Dogs; Itraconazole; Trypanosoma cruzi | 2022 |
Interaction of Amiodarone with Azoles Against Aspergillus Planktonic Cells and Biofilms in vitro.
Topics: Amiodarone; Antifungal Agents; Aspergillosis; Aspergillus; Azoles; Biofilms; Itraconazole; Microbial Sensitivity Tests; Plankton; Voriconazole | 2022 |